Atlas Trials

A 21-Day Topical Safety Study of Diltiazem Hydrochloride Using a Cumulative Irritant Patch Test Design

Clinical trial NCT01821274 · UNKNOWN

Trial details

NCT number
NCT01821274
Sponsor
Ventrus Biosciences, Inc
Status
UNKNOWN
Phase
Phase 1
Study type
INTERVENTIONAL
Skin Irritation
Start date
2013-03-01
Primary completion
2013-07-01
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.